Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2021 | MicroRNA panel for multiple sclerosis: potential biomarkers?

Bárbara Guerra Leal • 1 Jul 2021
EAN 2021
Multiple Sclerosis and Related Disorders

Bárbara Guerra Leal, PhD, University of Porto, Porto, Portugal, discusses the potential use of inflammatory microRNAs as biomarkers for predetermining the onset of MS. An initial trial provided positive results, but further testing is required in order to establish its efficacy. This interview took place during the European Academy of Neurology 2021 congress.

More from Bárbara Guerra Leal

2:08
IL-6 in mesial temporal lobe epilepsy development
Bárbara Guerra Leal • 8 Oct 2021
2:47
Inflammatory microRNA levels associate with worse disability in MS
Bárbara Guerra Leal • 8 Oct 2021
1:58
Impact of the ketogenic diet on inflammation-associated microRNAs in epilepsy
Bárbara Guerra Leal • 1 Jul 2021
1:15
Interleukin 1B in MS: analysis of a polymorphism in the gene promoter region
Bárbara Guerra Leal • 1 Jul 2021

Related Videos

3:44
Navigating intra-individual variability for early detection of cognitive decline
Leigh Charvet • 23 Feb 2024
5:42
Mapping the functional interactome in MS lesions to shed light on remyelination failure
Milos Opacic • 5 Mar 2024
3:26
Acupressure for the management of pain and anxiety in patients with MS
Megan Weigel • 4 Mar 2024
5:37
GAIT-HUB: a home-based gait monitoring system for patients with MS
Giuseppina Pilloni • 4 Mar 2024
The content of VJNeurology is intended for healthcare professionals